Will a pill a day prevent HIV? Anticipating the results of the tenofovir “PrEP” trials
This 2005 report examines the issues surrounding the tenofovir trials and makes recommendations for ensuring that trials are carried out ethically and that provisions are made for dealing with the results of the trials when they are available. The report also calls for more concerted coordination and advance planning to accelerate evaluation, licensing, and access to PrEP.
- Population:
- Gay and Bisexual Men Who Have Sex with Men
- Topics:
- Accelerating Product Innovation
- Tracking and Translating the Field
Was this content helpful?
Tell us how we can improve the content.
Was this content helpful?
Thank you for your feedback!